Purcura specializes in theranostic services that combine precision imaging and tailored therapies to provide personalized cancer treatment, particularly for prostate cancer. By utilizing advanced molecular imaging techniques, they enhance diagnostic accuracy and treatment effectiveness while ensuring affordability for patients across the United States.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional cancer treatment often lacks precision, leading to ineffective therapies and unnecessary side effects. Current diagnostic methods may not accurately visualize the extent and specific characteristics of the cancer, hindering the development of tailored treatment plans. This can result in suboptimal outcomes and increased costs for patients.
Solution
Purcura offers theranostic services that integrate advanced molecular imaging with targeted therapies to deliver personalized cancer treatment, with a focus on prostate cancer. By using precision imaging techniques, Purcura enhances the accuracy of cancer diagnosis and enables more effective and tailored treatment strategies. This approach combines diagnostics and therapy, allowing clinicians to visualize and treat cancer with greater precision. Purcura's commitment is to expand its offerings, bringing hope to more patients through innovative and accessible care.
Target Audience
Purcura's primary customers are cancer patients, particularly those with prostate cancer, seeking personalized and effective treatment options, as well as providers looking to enhance their cancer treatment offerings with theranostic services.
Features
- Molecular imaging for precise visualization of cancer intricacies.
- Theranostic approach combining diagnostics with targeted therapy.
- Innovative treatments focused on prostate cancer.
- Participation in clinical trials to pioneer breakthrough treatments.
- PET-CT imaging for precision diagnostics.
- State-of-the-art oncology facilities offering comprehensive cancer care.